Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0001477449-24-000189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-08-30 | TDOC | Cave James L. | INTERIM CAO | M - OptEx | — | +1,884 | 14.4K | +15% | — |
| D | 2024-09-04 | 2024-09-03 | TDOC | Cave James L. | INTERIM CAO | S - Sale+OE | $7.16 | -555 | 13.8K | -4% | -$3,974 |
| DM | 2024-09-04 | 2024-08-30 | TDOC | Cave James L. | INTERIM CAO | M - OptEx | $0.00 | -1,884 | 6,977 | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | M | A | 339 | — | 12,818 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| 2 | Common | Common Stock | 2024-08-30 | M | A | 383 | — | 13,201 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| 3 | Common | Common Stock | 2024-09-03 | S | D | 555 | $7.16 | 13,808 | D | — | — | (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. |
| 4 | Common | Common Stock | 2024-08-30 | M | A | 1,162 | — | 14,363 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. |
| 5 | Derivative | Restricted Stock Units | 2024-08-30 | M | D | 339 | $0.00 | 678 | D | — · — to — | 339 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2024-08-30 | M | D | 383 | $0.00 | 1,151 | D | — · — to — | 383 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F4) On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-08-30 | M | D | 1,162 | $0.00 | 6,977 | D | — · — to — | 1,162 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F5) On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |